These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29897466)

  • 61. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Sacar M; Sacar S; Kaleli I; Onem G; Turgut H; Goksin I; Ozcan V; Kaan Inan B; Duver H; Baltalarli A
    J Surg Res; 2007 May; 139(2):170-5. PubMed ID: 17292421
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vitro activity of daptomycin combined with dalbavancin and linezolid, and dalbavancin with linezolid against MRSA strains.
    Aktas G; Derbentli S
    J Antimicrob Chemother; 2017 Feb; 72(2):441-443. PubMed ID: 28073963
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Linezolid minimum inhibitory concentration (MIC) creep in methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates at a single Japanese center.
    Miyazaki M; Nagata N; Miyazaki H; Matsuo K; Takata T; Tanihara S; Kamimura H
    Biol Pharm Bull; 2014; 37(4):679-82. PubMed ID: 24694615
    [TBL] [Abstract][Full Text] [Related]  

  • 64. First Report of cfr-Carrying Plasmids in the Pandemic Sequence Type 22 Methicillin-Resistant Staphylococcus aureus Staphylococcal Cassette Chromosome mec Type IV Clone.
    Shore AC; Lazaris A; Kinnevey PM; Brennan OM; Brennan GI; O'Connell B; Feßler AT; Schwarz S; Coleman DC
    Antimicrob Agents Chemother; 2016 May; 60(5):3007-15. PubMed ID: 26953212
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Linezolid resistance: detection of the cfr(B) gene in French clinical MRSA strains.
    Youenou B; Martins Simoes P; Tristan A; Farfour E; Beauruelle C; Kolenda C; Ranc AG; Vandenesch F; Laurent F; Dupieux C
    J Antimicrob Chemother; 2023 Feb; 78(2):445-449. PubMed ID: 36509546
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluating linezolid dose regimens against methicillin-resistant Staphylococcus aureus based on renal function in populations with different body weight.
    Zuo M; Sun Y; Zhao X; Xu G; Wang N; Chen J; Zhu L; Yang W; Zhao M
    J Clin Pharm Ther; 2022 Dec; 47(12):2162-2169. PubMed ID: 36053892
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Experimental study of the efficacy of linezolid alone and in combinations against experimental meningitis due to Staphylococcus aureus strains with decreased susceptibility to beta-lactams and glycopeptides.
    Cabellos C; Garrigós C; Taberner F; Force E; Pachón-Ibañez ME
    J Infect Chemother; 2014 Sep; 20(9):563-8. PubMed ID: 24973908
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates.
    Sambatakou H; Giamarellos-Bourboulis EJ; Grecka P; Chryssouli Z; Giamarellou H
    J Antimicrob Chemother; 1998 Mar; 41(3):349-55. PubMed ID: 9578161
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
    Sahuquillo Arce JM; Colombo Gainza E; Gil Brusola A; Ortiz Estévez R; Cantón E; Gobernado M
    Rev Esp Quimioter; 2006 Sep; 19(3):252-7. PubMed ID: 17099793
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus.
    Morales G; Picazo JJ; Baos E; Candel FJ; Arribi A; Peláez B; Andrade R; de la Torre MA; Fereres J; Sánchez-García M
    Clin Infect Dis; 2010 Mar; 50(6):821-5. PubMed ID: 20144045
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Linezolid versus vancomycin for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus in the elderly: A retrospective cohort analysis: Effectiveness of linezolid in the elderly.
    Takada H; Hifumi T; Nishimoto N; Kanemura T; Yoshioka H; Okada I; Kiriu N; Inoue J; Koido Y; Kato H
    Am J Emerg Med; 2017 Feb; 35(2):245-248. PubMed ID: 27832976
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Oral-Only Linezolid-Rifampin Is Highly Effective Compared with Other Antibiotics for Periprosthetic Joint Infection: Study of a Mouse Model.
    Thompson JM; Saini V; Ashbaugh AG; Miller RJ; Ordonez AA; Ortines RV; Wang Y; Sterling RS; Jain SK; Miller LS
    J Bone Joint Surg Am; 2017 Apr; 99(8):656-665. PubMed ID: 28419033
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
    Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
    Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus.
    Leonard SN; Kaatz GW; Rucker LR; Rybak MJ
    J Antimicrob Chemother; 2008 Dec; 62(6):1305-10. PubMed ID: 18801920
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy of combination oral antimicrobial agents against biofilm-embedded methicillin-resistant Staphylococcus aureus.
    Wu WS; Chen CC; Chuang YC; Su BA; Chiu YH; Hsu HJ; Ko WC; Tang HJ
    J Microbiol Immunol Infect; 2013 Apr; 46(2):89-95. PubMed ID: 22572005
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synergistic effect of linezolid with fosfomycin against Staphylococcus aureus in vitro and in an experimental Galleria mellonella model.
    Li L; Chen H; Liu Y; Xu S; Wu M; Liu Z; Qi C; Zhang G; Li J; Huang X
    J Microbiol Immunol Infect; 2020 Oct; 53(5):731-738. PubMed ID: 30638785
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular characterization of resistance to Rifampicin in an emerging hospital-associated Methicillin-resistant Staphylococcus aureus clone ST228, Spain.
    Mick V; Domínguez MA; Tubau F; Liñares J; Pujol M; Martín R
    BMC Microbiol; 2010 Mar; 10():68. PubMed ID: 20202188
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In Vitro and In Vivo Synergy of the Oxadiazole Class of Antibacterials with β-Lactams.
    Janardhanan J; Meisel JE; Ding D; Schroeder VA; Wolter WR; Mobashery S; Chang M
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5581-8. PubMed ID: 27401567
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Characterization of pig-associated methicillin-resistant Staphylococcus aureus.
    Li J; Jiang N; Ke Y; Feßler AT; Wang Y; Schwarz S; Wu C
    Vet Microbiol; 2017 Mar; 201():183-187. PubMed ID: 28284608
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis.
    Lefebvre M; Jacqueline C; Amador G; Le Mabecque V; Miegeville A; Potel G; Caillon J; Asseray N
    Int J Antimicrob Agents; 2010 Dec; 36(6):542-4. PubMed ID: 20851576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.